Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Clinical and Translational Radiation Oncology|April 20, 2026
Phase II randomized trial of 41.4 Gy vs. 50.4 Gy in neoadjuvant chemoradiotherapy for resectable esophageal cancerEbrahim Esmati, Reza Nazari, Ali Aqamolaei, et al.Journal of Contemporary Brachytherapy|December 25, 2024
Surface mold brachytherapy for head and neck non-melanoma skin cancer - local control rates and survival: A retrospective analysisEbrahim Esmati, Romina Abyaneh, Ramin Jaberi, et al.Cancer Medicine|June 30, 2022
Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019Sina Azadnajafabad, Sahar Saeedi Moghaddam, Mohammad Keykhaei, et al.Plos One|September 8, 2025
"Colorectal Cancer Care Quality in a Developing Country: Insights from a Comparison of Teaching and Non-teaching Hospitals in Iran"Mohammad Reza Rouhollahi, Mahdi Aghili, Saeed Nemati, et al.Journal of Gastrointestinal Cancer|June 26, 2023
Global, Regional, and National Quality of Care Index (QCI) of Gastric Cancer: A Systematic Analysis for the Global Burden of Disease Study 1990-2017Nima Fattahi, Ali Ghanbari, Shirin Djalalinia, et al.Radiation Oncology Journal|January 3, 2025
Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients: a real-world single institution experienceReza Ghalehtaki, Kasra Kolahdouzan, Guglielmo Niccolò Piozzi, et al.Medical Journal of the Islamic Republic of Iran|January 13, 2021
Management of colon and rectal cancers during COVID-19 pandemic: A clinical guideline (TUMS-CRC-CoV19 Guideline)Mohammad Reza Keramati, Behnam Behboudi, Seyed Mohsen Ahmadi-Tafti, et al.Radiation Oncology (London, England)|December 3, 2024
Short-term and long-term oncological outcomes of chemoradiotherapy for rectal cancer patients with or without oxaliplatin: a propensity score-matched retrospective analysisAmirali Azimi, Fatemeh Sadat Tabatabaei, Kasra Kolahdouzan, et al.International Journal of Colorectal Disease|May 4, 2026
Complete pathologic response surrogacy for survival and its predictors in locally advanced rectal cancer: a retrospective cohort studyReza Ghalehtaki, Romina Abyaneh, Samaneh Salarvand, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 25, 2025
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study - ATLANTIS part ILuca Nicosia, Marco Lorenzo Bonù, Ilaria Angelicone, et al.Pageof 7